EliaEnidAcevedo-DiazMD

Psychiatry • Gaithersburg, MD

Psychosomatic Medicine, Clinical Pharmacology

Principal Investigator

Join to view full profile

Dr. Acevedo-Diaz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Acevedo-Diaz's full profile

Already have an account?

Office
9318 Gaither Rd
Ste 220
Gaithersburg, MD 20877
Phone+1 301-251-4702

Fax+1 301-251-4703

Education & Training

Clinical Center at the National Institutes of HealthFellowship, Experimental Therapeutics and Pathophysiology Branch (ETPB) - NIMH, 2018 - 2020
Clinical Center at the National Institutes of HealthFellowship, Psychosomatic Medicine, 2017 - 2018
Boston University Medical CenterResidency, Psychiatry, 2014 - 2017
San Juan City HospitalInternship, Transitional Year, 2013 - 2014
University of Puerto Rico School of MedicineClass of 2013

Certifications & Licensure

MD State Medical License 2017 - 2026
MA State Medical License 2014 - 2018
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers Start of enrollment: 2001 Feb 02
Recruiting
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations Start of enrollment: 2013 Jul 24
Recruiting
Phase 2
Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder Start of enrollment: 2015 Oct 14
Completed
Phase 2
Neurobiology of Suicide Start of enrollment: 2015 Dec 01
Recruiting
Phase 2
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder Start of enrollment: 2017 May 25
Recruiting
Phase 1
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes Start of enrollment: 2018 May 17
Recruiting
Not Applicable
Development of Non-Invasive Brain Stimulation Techniques Start of enrollment: 2018 Jan 11
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

49 citations
The influence of ketamine on drug discovery in depression.
Christoph Kraus, Daniel Wasserman, Ioline D. Henter, Elia E. Acevedo-Diaz, Bashkim Kadriu
Drug Discovery Today. 2019-10-01
59 citations
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression.
Elia E. Acevedo-Diaz, Grace W. Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu
Journal of Affective Disorders. 2020-02-15
20 citations
Can ‘floating’ predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression
Elia E. Acevedo-Diaz, Grace W. Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu
Journal of Psychiatric Research. 2020-11-01

Professional Memberships

American Psychiatric Association - APA
Member
American Association of Geriatric Psychiatry - AAGP
Member

Other Languages

Spanish